News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,501 Results
Type
Article (14099)
Company Profile (282)
Press Release (250120)
Section
Business (79465)
Career Advice (152)
Deals (13219)
Drug Delivery (35)
Drug Development (50404)
Employer Resources (31)
FDA (5702)
Job Trends (5124)
News (144308)
Policy (10024)
Tag
Academia (905)
Alliances (21605)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5704)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40565)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1278)
Earnings (29215)
Events (47655)
Executive appointments (353)
FDA (6208)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1071)
Healthcare (6569)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7248)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2576)
Medtech (2577)
Mergers & acquisitions (6205)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1339)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25358)
Phase I (14317)
Phase II (18879)
Phase III (11920)
Pipeline (504)
Postmarket research (852)
Preclinical (5996)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1414)
Regulatory (8438)
Research institute (932)
Series A (82)
Southern California (1188)
Startups (1968)
United States (10532)
Vaccines (189)
Weight loss (96)
Date
Today (8)
Last 7 days (339)
Last 30 days (1515)
Last 365 days (20405)
2025 (2645)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7533)
2011 (7614)
2010 (7429)
Location
Africa (148)
Asia (17095)
Australia (2893)
California (3047)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36810)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1339)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1188)
Texas (337)
Washington State (291)
264,501 Results for "addex therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Addex to Present at the 2025 Swiss Equities Baader Conference
January 8, 2025
·
3 min read
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
Addex Therapeutics, a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, reported its Q1 2024 financial results and provided a corporate update.
June 6, 2024
·
7 min read
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Addex Therapeutics announced the launch of Neurosterix, a company focused on developing allosteric modulators for the treatment of underserved neurological disorders.
April 3, 2024
·
7 min read
Addex to Present at Bio€quity Europe 2024
Addex Therapeutics announced that CEO, Tim Dyer, will present at the Bio€quity Europe 2024 conference taking place May 12 - 14, 2024 at the Kursaal Congress Center in San Sebastián, Spain.
May 8, 2024
·
3 min read
Addex Convenes Annual General Meeting 2024
Addex Therapeutics, a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced that its 2024 Annual General Meeting will take place on Friday June 28, 2024, at 11:00 am CEST at the Campus Biotech, Chemin des Mines 9, 1202 Geneva.
June 5, 2024
·
5 min read
Business
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported its full-year 2023 financial results for the period ended December 31, 2023 and provided a corporate update.
April 18, 2024
·
7 min read
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced that it will issue its Full-Year 2023 Financial Results on April 18, 2024.
April 11, 2024
·
3 min read
Press Releases
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 22, 2024
·
9 min read
Press Releases
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
September 30, 2024
·
9 min read
Addex to Present at the Bio-Europe Spring 2024 Conference
Addex Therapeutics announced that CEO, Tim Dyer, will present at the Bio-Europe Spring 2024 conference taking place March 18 - 20, 2024 in Barcelona, Spain.
March 14, 2024
·
3 min read
1 of 26,451
Next
